Pinnacle Wealth Management Advisory Group LLC Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Pinnacle Wealth Management Advisory Group LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 8,377 shares of the healthcare conglomerate’s stock after purchasing an additional 306 shares during the quarter. Pinnacle Wealth Management Advisory Group LLC’s holdings in UnitedHealth Group were worth $4,238,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. M&T Bank Corp lifted its holdings in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC raised its stake in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after acquiring an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its stake in UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP purchased a new position in UnitedHealth Group in the 3rd quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on UNH shares. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 1.4 %

UNH opened at $523.48 on Friday. The firm has a market capitalization of $481.75 billion, a price-to-earnings ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company’s 50 day simple moving average is $523.11 and its two-hundred day simple moving average is $563.18. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.